CellSeed Inc logo

7776 - CellSeed Inc News Story

¥256 2.0  0.8%

Last Trade - 15/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £28.8m
Enterprise Value £20.8m
Revenue £1.05m
Position in Universe 3259th / 3893

TABLE-CellSeed -2019 group results

Fri 14th February, 2020 7:00am
Feb 14 (Reuters)- 
          CellSeed Inc. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended        Year to         NEXT     
                Dec 31, 2019    Dec 31, 2018    Dec 31, 2020       YEAR       
                   LATEST         YEAR-AGO         COMPANY         COMPANY    
                   RESULTS         RESULTS        FORECAST       H1 FORECAST  
  Sales            275 mln          1.03           310 mln         84 mln     
                 (-73.1 pct)                     (+12.4 pct)     (-48.3 pct)  
  Operating     loss 780 mln       140 mln        loss 1.02     loss 570 mln  
  Recurring     loss 786 mln       140 mln        loss 1.02     loss 570 mln  
  Net
  Net           loss 782 mln       129 mln        loss 1.02     loss 570 mln  
  EPS          loss 66.60 yen     11.35 yen    loss 78.57 yen  loss 43.91 yen 
  EPS Diluted                     11.27 yen                                   
  Ann Div            NIL             NIL             NIL                      
  -Q2 Div            NIL             NIL             NIL                      
  -Q4 Div            NIL             NIL             NIL                      
  
  NOTE - CellSeed Inc..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7776.T
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.